Locations:
Search IconSearch
September 19, 2017/Cancer/News & Insight

ASTRO 2017 – Monday, September 25

Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASTRO Annual Meeting

17-CNR-4279_650x450

Monday, September 25

Poster Viewing Q&A 3: Breast, GYN, Nursing
Hall A-B1, Ground Level

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

10:45AM

Poster Q&A
Charles Leyrer, MD
The Importance of Treatment and Timing in Metaplastic Breast Cancer

Poster Viewing Q&A 4: Physics
Hall A-B1, Ground Level
4:15PM

Poster Q&A
Bingqi Guo, PhD
Surface Guided Radiation Therapy (SGRT): The Sensitivity of the Region of Interest (ROI) Selection on the Translational and Rotational Accuracy for Whole Breast Irradiation

Poster Q&A
Lei Qiu, MD
Auto-Contour Guided Prostate Patient Positioning

Poster Q&A
Andrew Godley, PhD
Prostate SBRT Intrafraction Monitoring with Transperineal Ultrasound

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad